News

  • INTEGRAGEN SUPPORTS THE ANTOINE LACASSAGNE CENTER IN NICE FOR A LARGE-SCALE RESEARCH PROJECT ON COLORECTAL CANCER PATIENTS 

    Founded in 1961, the Centre Antoine Lacassagne is one of the 18 Cancer Centers in the UNICANCER network in France. The Center's mission is to... Read More

  • NEW LOOK. NEW PORTFOLIO. NEW OPPORTUNITIES.

    FOLLOWING ITS ACQUISITION BY ONCODNA, INTEGRAGEN HAS UNDERGONE A COMPLETE OVERHAUL AND IS NOW READY TO EMBARK ON NEW PROJECTS IN THE FIELDS OF CANCER AND... Read More

  • POTENTIAL INVOLVEMENT OF URINARY TRACT INFECTIONS IN THE DEVELOPMENT OF BLADDER CANCER

    Uropathogenic E.coli induces DNA damage in the bladder As provider of the whole genome sequencing, IntegraGen is proud of sharing this new publication. Background Urinary tract infections (UTIs) are... Read More

  • NEW LOOK. NEW PORTFOLIO. NEW OPPORTUNITIES.

    FOLLOWING ITS ACQUISITION BY ONCODNA, INTEGRAGEN HAS UNDERGONE A COMPLETE OVERHAUL AND IS NOW... Read More

  • POTENTIAL INVOLVEMENT OF URINARY TRACT INFECTIONS IN THE DEVELOPMENT OF BLADDER CANCER

    Uropathogenic E.coli induces DNA damage in the bladder As provider of the whole genome sequencing, IntegraGen... Read More

  • NEW PERSPECTIVES IN THE DIAGNOSIS AND TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY

    Myogenesis modelled by human pluripotent stem cells: a multi-omic study of Duchenne myopathy early onset... Read More

  • BRIEF TECHNIQUE: LOW-PASS WHOLE GENOME SEQUENCING - GETTING MORE FROM LESS

    LP-WGS analysis of liquid biopsies (ctDNA) for oncology applications Background Analysis of circulating tumor DNA... Read More

en_US